Efficacy, Safety, and Biomarker Analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN Study).
Journal for ImmunoTherapy of Cancer(2021)
Key words
head and neck neoplasms,immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined